Pub Date : 2023-11-13DOI: 10.1021/cen-10137-cover12
None Matt Blois, None Alex Scott
Flo Materials makes endlessly recyclable plastics Shoes, carpets, and packaging are each made from several types of plastic, which makes them hard to recycle. In addition, some types of plastic start to degrade after being repeatedly recycled. The start-up Flo Materials, founded in 2021, is trying to commercialize a group of vitrimer plastics called enamine covalent adaptive networks (ECANs). These can be recycled endlessly, even if they are combined with other materials. The company, which is located in Berkeley, California, says its recycling process, based on research from Lawrence Berkeley National Laboratory , breaks down the plastic to monomers that are just as good as virgin materials. It also removes colors, contaminants, and additives. Flo CEO Kezi Cheng says that like high- performance thermosetting polymers, such as epoxy or polyurethane foam, her company’s materials are resistant to heat and chemical degradation. The bonds that make thermoset materials strong also make
{"title":"On our radar","authors":"None Matt Blois, None Alex Scott","doi":"10.1021/cen-10137-cover12","DOIUrl":"https://doi.org/10.1021/cen-10137-cover12","url":null,"abstract":"Flo Materials makes endlessly recyclable plastics Shoes, carpets, and packaging are each made from several types of plastic, which makes them hard to recycle. In addition, some types of plastic start to degrade after being repeatedly recycled. The start-up Flo Materials, founded in 2021, is trying to commercialize a group of vitrimer plastics called enamine covalent adaptive networks (ECANs). These can be recycled endlessly, even if they are combined with other materials. The company, which is located in Berkeley, California, says its recycling process, based on research from Lawrence Berkeley National Laboratory , breaks down the plastic to monomers that are just as good as virgin materials. It also removes colors, contaminants, and additives. Flo CEO Kezi Cheng says that like high- performance thermosetting polymers, such as epoxy or polyurethane foam, her company’s materials are resistant to heat and chemical degradation. The bonds that make thermoset materials strong also make","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"28 22","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136282583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-reactions
NUCLEAR POWER Reactions ShareShare onFacebookTwitterWechatLinked InRedditEmail C&EN, 2023, 101 (37), p 3November 13, 2023Cite this:C&EN 101, 37, 3Letters to the editorNuclear wasteA provocative editorial in every sense of the word (Sept. 18, 2023, page 2). Yes, we do have a looming disaster of our impact on the global climate, one that will remain well beyond our remaining lifetimes today. Yes, urgent action is required. However, I would like to suggest that conventional nuclear power is not the solution, or even close to it. There are several reasons. I shall stick with one, not the elephant in the room but the mastodon in the room: nuclear waste.Mitch Jacoby mentions permanent repositories. In their current form these are major environmental disasters waiting to happen. Why? The main reason is that even with the vitrification technologies of today, it is near impossible to understand the chemistry, the materials science, and the physics of these matrices in 100 years, 1,000 years, or 1 million years in the future. Evidence from Hanford and continuing efforts of its cleanup tell us much of what to expect to happen in these so-called permanent repositories.If we do go this route, they will need to remain permanently accessible for the continued reprocessing for several hundreds of thousands of years—potentially longer periods. Imagine what the person-hour rate would be in 500,000 years. Imagine how people will look back on the generation that created this waste. Of course, this assumes we do not develop technologies to deal with this waste in the future, which we well might; however, the waste still needs to be accessible. It is of course possible that this waste would undergo subduction into the mantle. A proper life-cycle analysis (ISO 144040), including the continuous waste reprocessing cycles for several thousands of years, would show it to be a very expensive energy source, indeed.Paul JonsenHarrogate, EnglandNowhere in “Can Small Modular Reactors Save Nuclear Energy?” was there a mention of how the waste from these reactors will be disposed of (Sept. 11, 2023, page 30). Maybe we should figure out what to do with the mountains of nuclear waste already created over the last 7 decades of nuclear power generation before we start generating more.Jim SchulteCicero, Illinois CorrectionsSept. 18, 2023, page 40: Newscripts has an incorrect print publication date. It was published in the Sept. 18, not Sept. 11, issue.Oct. 23, 2023, page 30: A quote in the cover story on cool-roof coatings incorrectly implies that Victoria Scarborough is affiliated with the Cool Roof Rating Council. She was instead pointing to the group as a resource.Oct. 30, 2023, page 14: A business news story about Roche’s acquisition of Telavant Holdings describes Roche incorrectly. The company is Swiss, not French.Oct. 30, 2023, page 28: The cover story on small-molecule drugs gives an incorrect affiliation for Matthew Disney. He is based at the Herbert Wertheim UF Scripps Instit
核能反应分享分享在facebook上推特上推特上链接在reddite电子邮件引用:C&EN, 2023,101 (37)， p 32311月13日引用:C&EN, 101,37,3给编辑的信核废料一篇在任何意义上都具有挑衅意味的社论(2023年9月18日，第2页)。是的，我们确实有一场迫在眉睫的灾难，我们对全球气候的影响将远远超过我们今天的余生。是的，需要采取紧急行动。然而，我想说的是，传统的核能不是解决办法，甚至不是接近解决办法。有几个原因。我将坚持讲一个，不是房间里的大象，而是房间里的乳齿象:核废料。Mitch Jacoby提到了永久存储库。以目前的形式来看，这些都是即将发生的重大环境灾难。为什么?主要原因是，即使使用今天的玻璃化技术，也几乎不可能在100年、1000年或100万年后了解这些基质的化学、材料科学和物理学。来自汉福德的证据和持续的清理工作告诉我们，在这些所谓的永久储存库中会发生什么。如果我们真的走这条路，它们将需要在几十万年——可能更长——的时间里保持永久的可访问性，以便继续进行再处理。想象一下50万年后每小时的速度会是多少。想象一下，人们将如何回顾制造这种浪费的一代人。当然，这是假设我们将来不开发处理这些废物的技术，而我们很可能会这样做;然而，废物仍然需要是可获取的。当然，这些废物也有可能俯冲到地幔中。适当的生命周期分析(ISO 144040)，包括持续数千年的废物再处理循环，将表明它确实是一种非常昂贵的能源。《小型模块化反应堆能拯救核能吗?》有没有提到如何处理这些反应堆产生的废料(2023年9月11日，第30页)。也许在我们开始生产更多的核废料之前，我们应该弄清楚如何处理过去70年核电产生的堆积如山的核废料。Jim SchulteCicero，伊利诺斯州惩教所2023年18日，第40页:Newscripts的印刷出版日期不正确。这篇文章发表在9月18日，而不是9月11日。2023年3月23日，第30页:封面故事中关于凉爽屋顶涂料的引用错误地暗示维多利亚·斯卡伯勒隶属于凉爽屋顶评级委员会。相反，她指出该组织是一种资源。2023年3月30日，第14页:一篇关于罗氏收购Telavant Holdings的商业新闻报道错误地描述了罗氏。这家公司是瑞士的，不是法国的。2023年3月30日，第28页:关于小分子药物的封面故事给了马修·迪斯尼一个错误的归属。他就职于佛罗里达大学赫伯特·韦特海姆UF斯克里普斯生物医学创新与技术研究所，而不是斯克里普斯研究所。下载
{"title":"Reactions","authors":"","doi":"10.1021/cen-10137-reactions","DOIUrl":"https://doi.org/10.1021/cen-10137-reactions","url":null,"abstract":"NUCLEAR POWER Reactions ShareShare onFacebookTwitterWechatLinked InRedditEmail C&EN, 2023, 101 (37), p 3November 13, 2023Cite this:C&EN 101, 37, 3Letters to the editorNuclear wasteA provocative editorial in every sense of the word (Sept. 18, 2023, page 2). Yes, we do have a looming disaster of our impact on the global climate, one that will remain well beyond our remaining lifetimes today. Yes, urgent action is required. However, I would like to suggest that conventional nuclear power is not the solution, or even close to it. There are several reasons. I shall stick with one, not the elephant in the room but the mastodon in the room: nuclear waste.Mitch Jacoby mentions permanent repositories. In their current form these are major environmental disasters waiting to happen. Why? The main reason is that even with the vitrification technologies of today, it is near impossible to understand the chemistry, the materials science, and the physics of these matrices in 100 years, 1,000 years, or 1 million years in the future. Evidence from Hanford and continuing efforts of its cleanup tell us much of what to expect to happen in these so-called permanent repositories.If we do go this route, they will need to remain permanently accessible for the continued reprocessing for several hundreds of thousands of years—potentially longer periods. Imagine what the person-hour rate would be in 500,000 years. Imagine how people will look back on the generation that created this waste. Of course, this assumes we do not develop technologies to deal with this waste in the future, which we well might; however, the waste still needs to be accessible. It is of course possible that this waste would undergo subduction into the mantle. A proper life-cycle analysis (ISO 144040), including the continuous waste reprocessing cycles for several thousands of years, would show it to be a very expensive energy source, indeed.Paul JonsenHarrogate, EnglandNowhere in “Can Small Modular Reactors Save Nuclear Energy?” was there a mention of how the waste from these reactors will be disposed of (Sept. 11, 2023, page 30). Maybe we should figure out what to do with the mountains of nuclear waste already created over the last 7 decades of nuclear power generation before we start generating more.Jim SchulteCicero, Illinois CorrectionsSept. 18, 2023, page 40: Newscripts has an incorrect print publication date. It was published in the Sept. 18, not Sept. 11, issue.Oct. 23, 2023, page 30: A quote in the cover story on cool-roof coatings incorrectly implies that Victoria Scarborough is affiliated with the Cool Roof Rating Council. She was instead pointing to the group as a resource.Oct. 30, 2023, page 14: A business news story about Roche’s acquisition of Telavant Holdings describes Roche incorrectly. The company is Swiss, not French.Oct. 30, 2023, page 28: The cover story on small-molecule drugs gives an incorrect affiliation for Matthew Disney. He is based at the Herbert Wertheim UF Scripps Instit","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"28 19","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136282585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-polcon4
None Britt E. Erickson
After decades with little progress, the US Environmental Protection Agency plans to revamp an effort to evaluate pesticides for potential effects on estrogen, androgen, and thyroid hormones. The move follows a late-2022 lawsuit from environmental and farmworker groups and a scathing 2021 report from the EPA’s Office of Inspector General over endocrine disruptor testing delays. The EPA’s beleaguered Endocrine Disruptor Screening Program, created in 1998 to comply with changes to US food and drinking-water laws, has been on hiatus with no “effective internal controls in place since 2015,” according to the 2021 report. To get the program back on track, the EPA will request data from manufacturers for 30 pesticides that showed estrogen or androgen activity when agency scientists tested them with high-throughput assays and computational modeling , the agency announced Oct. 26. The 30 high-priority pesticides are part of a group of 403 pesticides that the EPA is reviewing
{"title":"EPA to rebuild endocrine disruptor program","authors":"None Britt E. Erickson","doi":"10.1021/cen-10137-polcon4","DOIUrl":"https://doi.org/10.1021/cen-10137-polcon4","url":null,"abstract":"After decades with little progress, the US Environmental Protection Agency plans to revamp an effort to evaluate pesticides for potential effects on estrogen, androgen, and thyroid hormones. The move follows a late-2022 lawsuit from environmental and farmworker groups and a scathing 2021 report from the EPA’s Office of Inspector General over endocrine disruptor testing delays. The EPA’s beleaguered Endocrine Disruptor Screening Program, created in 1998 to comply with changes to US food and drinking-water laws, has been on hiatus with no “effective internal controls in place since 2015,” according to the 2021 report. To get the program back on track, the EPA will request data from manufacturers for 30 pesticides that showed estrogen or androgen activity when agency scientists tested them with high-throughput assays and computational modeling , the agency announced Oct. 26. The 30 high-priority pesticides are part of a group of 403 pesticides that the EPA is reviewing","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"29 21","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136281522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-buscon7
None Craig Bettenhausen
The investment firm BlackRock will put $550 million into a direct-air-capture (DAC) project being developed by a subsidiary of the oil and gas giant Occidental. Under the terms of the deal, BlackRock and Oxy will form a joint venture that will own Stratos, a DAC facility that Oxy is building in Texas. When the plant comes on-line in 2025, the firms expect it to remove 500,000 metric tons of carbon dioxide per year from the ambient air. In August, Oxy bought Carbon Engineering, the DAC technology provider for the project, for $1.1 billion.
{"title":"Blackrock invests in direct air capture","authors":"None Craig Bettenhausen","doi":"10.1021/cen-10137-buscon7","DOIUrl":"https://doi.org/10.1021/cen-10137-buscon7","url":null,"abstract":"The investment firm BlackRock will put $550 million into a direct-air-capture (DAC) project being developed by a subsidiary of the oil and gas giant Occidental. Under the terms of the deal, BlackRock and Oxy will form a joint venture that will own Stratos, a DAC facility that Oxy is building in Texas. When the plant comes on-line in 2025, the firms expect it to remove 500,000 metric tons of carbon dioxide per year from the ambient air. In August, Oxy bought Carbon Engineering, the DAC technology provider for the project, for $1.1 billion.","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"29 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136281530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-buscon17
None Rick Mullin
Almac has published details of a $98 million investment program that will expand its pharmaceutical and diagnostic service units with manufacturing and laboratory assets at its headquarters in Craigavon, Northern Ireland. Plans include a 9,300 m 2 production facility supporting oral dosage drugs and a 3,700 m 2 development center with diagnostic kit manufacturing facilities. Alma, which has set a recruitment goal of 1,000 new staffers in Northern Ireland over 3 years, says this expansion will create more than 550 jobs.
{"title":"Almac details expansion plans","authors":"None Rick Mullin","doi":"10.1021/cen-10137-buscon17","DOIUrl":"https://doi.org/10.1021/cen-10137-buscon17","url":null,"abstract":"Almac has published details of a $98 million investment program that will expand its pharmaceutical and diagnostic service units with manufacturing and laboratory assets at its headquarters in Craigavon, Northern Ireland. Plans include a 9,300 m 2 production facility supporting oral dosage drugs and a 3,700 m 2 development center with diagnostic kit manufacturing facilities. Alma, which has set a recruitment goal of 1,000 new staffers in Northern Ireland over 3 years, says this expansion will create more than 550 jobs.","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"29 23","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136281520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-buscon10
None Matt Blois
The chemical firm Ashland is scaling back production of the food and cosmetic ingredients carboxymethyl cellulose, methyl cellulose, and hydroxyethyl cellulose in response to low demand. The company also plans to sell its nutraceuticals business. Ashland recently announced that it will focus on industries in which it has the biggest technology advantage, such as ingredients for pharmaceuticals, personal care products, and coatings. The firm sold its adhesives business to Arkema for $1.65 billion in 2022 .
{"title":"Ashland plans restructuring","authors":"None Matt Blois","doi":"10.1021/cen-10137-buscon10","DOIUrl":"https://doi.org/10.1021/cen-10137-buscon10","url":null,"abstract":"The chemical firm Ashland is scaling back production of the food and cosmetic ingredients carboxymethyl cellulose, methyl cellulose, and hydroxyethyl cellulose in response to low demand. The company also plans to sell its nutraceuticals business. Ashland recently announced that it will focus on industries in which it has the biggest technology advantage, such as ingredients for pharmaceuticals, personal care products, and coatings. The firm sold its adhesives business to Arkema for $1.65 billion in 2022 .","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"29 16","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136281525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-cover9
None Laurel Oldach
There are hundreds of G protein–coupled receptors (GPCRs) in the human genome, regulating just about every physiological system. While roughly a third of marketed drugs target a GPCR, many of the receptors have remained out of reach for drug hunters, in part because of challenges involved in studying them . After the heyday of GPCR-targeting drugs in the 1990s and early 2000s, few medicines targeting these proteins have been introduced. But new technologies may be poised to change that. A few years ago, chemistry Nobel laureate Robert J. Lefkowitz was working with scientists in his lab at Duke University in North Carolina to develop a new way to isolate enzymatically active GPCRs. Halfway around the world, at Monash University in Melbourne, Australia, the eminent pharmacology duo Patrick Sexton and Arthur Christopoulos was simultaneously developing techniques to modulate GPCR signaling using structure-based drug design. And in San Francisco, Jeffrey Finer, a
人类基因组中有数百个G蛋白偶联受体(gpcr)，它们调节着几乎所有的生理系统。虽然大约有三分之一的上市药物靶向GPCR，但许多受体仍然是药物猎人无法触及的，部分原因是研究它们所涉及的挑战。在20世纪90年代和21世纪初gpcr靶向药物的鼎盛时期之后，很少有针对这些蛋白质的药物被引入。但新技术可能会改变这种状况。几年前，诺贝尔化学奖得主罗伯特·j·莱夫科维茨(Robert J. Lefkowitz)在北卡罗来纳州杜克大学(Duke University)的实验室里与科学家们合作，开发了一种分离酶活性gpcr的新方法。在地球的另一端，澳大利亚墨尔本的莫纳什大学，著名的药理学二人组Patrick Sexton和Arthur Christopoulos正在同时开发利用基于结构的药物设计来调节GPCR信号的技术。在旧金山，一位名叫杰弗里
{"title":"Septerna","authors":"None Laurel Oldach","doi":"10.1021/cen-10137-cover9","DOIUrl":"https://doi.org/10.1021/cen-10137-cover9","url":null,"abstract":"There are hundreds of G protein–coupled receptors (GPCRs) in the human genome, regulating just about every physiological system. While roughly a third of marketed drugs target a GPCR, many of the receptors have remained out of reach for drug hunters, in part because of challenges involved in studying them . After the heyday of GPCR-targeting drugs in the 1990s and early 2000s, few medicines targeting these proteins have been introduced. But new technologies may be poised to change that. A few years ago, chemistry Nobel laureate Robert J. Lefkowitz was working with scientists in his lab at Duke University in North Carolina to develop a new way to isolate enzymatically active GPCRs. Halfway around the world, at Monash University in Melbourne, Australia, the eminent pharmacology duo Patrick Sexton and Arthur Christopoulos was simultaneously developing techniques to modulate GPCR signaling using structure-based drug design. And in San Francisco, Jeffrey Finer, a","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"26 25","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136282421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-buscon9
None Matt Blois
The Goodyear Tire & Rubber Company is working with the biomanufacturing firm Visolis to develop a process for producing biobased isoprene, a precursor for some types of synthetic rubber used to make tires. Isoprene is typically made as a by-product of oil refining. Visolis plans to make the chemical from lignocellulosic feedstock, which is inedible biomass. In 2007, Goodyear entered into a partnership with Genencor to produce isoprene enzymatically from plant sugars. The partners initially hoped to commercialize the product by 2013 but haven’t announced additional progress.
{"title":"Goodyear, Visolis plan biobased isoprene","authors":"None Matt Blois","doi":"10.1021/cen-10137-buscon9","DOIUrl":"https://doi.org/10.1021/cen-10137-buscon9","url":null,"abstract":"The Goodyear Tire & Rubber Company is working with the biomanufacturing firm Visolis to develop a process for producing biobased isoprene, a precursor for some types of synthetic rubber used to make tires. Isoprene is typically made as a by-product of oil refining. Visolis plans to make the chemical from lignocellulosic feedstock, which is inedible biomass. In 2007, Goodyear entered into a partnership with Genencor to produce isoprene enzymatically from plant sugars. The partners initially hoped to commercialize the product by 2013 but haven’t announced additional progress.","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"28 9","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136282595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-buscon3
None Craig Bettenhausen
Clariant has agreed to buy the personal care ingredient maker Lucas Meyer Cosmetics from International Flavors & Fragrances (IFF) for $810 million. The deal also includes another ingredient brand, IBR, as well as 195 employees and six research and production sites around the world. Clariant CEO Conrad Keijzer said on an Oct. 30 call with analysts that IFF’s cosmetic ingredient business had a profit margin of almost 50% on sales of $100 million in 2022. The firm aims to increase sales to $180 million by 2028. IFF bought Lucas Meyer in 2015 for $305 million. But after its 2021 merger with DuPont’s nutrition and biosciences business, IFF has been restructuring to focus on nutrition, scent, and health-care markets. It sold a microbial control business to Lanxess last year and two specialty flavoring units to private equity firms earlier this year . On the call, Keijzer said cosmetic ingredients are “one
{"title":"Clariant to purchase Lucas Meyer Cosmetics","authors":"None Craig Bettenhausen","doi":"10.1021/cen-10137-buscon3","DOIUrl":"https://doi.org/10.1021/cen-10137-buscon3","url":null,"abstract":"Clariant has agreed to buy the personal care ingredient maker Lucas Meyer Cosmetics from International Flavors & Fragrances (IFF) for $810 million. The deal also includes another ingredient brand, IBR, as well as 195 employees and six research and production sites around the world. Clariant CEO Conrad Keijzer said on an Oct. 30 call with analysts that IFF’s cosmetic ingredient business had a profit margin of almost 50% on sales of $100 million in 2022. The firm aims to increase sales to $180 million by 2028. IFF bought Lucas Meyer in 2015 for $305 million. But after its 2021 merger with DuPont’s nutrition and biosciences business, IFF has been restructuring to focus on nutrition, scent, and health-care markets. It sold a microbial control business to Lanxess last year and two specialty flavoring units to private equity firms earlier this year . On the call, Keijzer said cosmetic ingredients are “one","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"28 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136282597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1021/cen-10137-scicon1
None Laurel Oldach
Artificial intelligence and machine learning tools are already being used to power voice assistants and self-driving cars, determine what users see on the internet, and guide drug design and chemical syntheses. But there are concerns about their ability to push disinformation, compromise cybersecurity, and engineer harmful biological materials. Governments around the world hope to mitigate those risks without quashing progress in the problems that AI seems poised to solve. A recent executive order by US president Joe Biden announced measures to make AI systems safer, such as requiring their developers to search for ways that bad actors could exploit the tools. Shortly after the order’s announcement , government and corporation representatives gathered in the UK for a summit on the risks of AI; 28 countries signed a declaration that supports continuing development of the technology but calls for more research into its potential risks. Many parts of the chemical enterprise
{"title":"Regulators, researchers develop AI safeguards","authors":"None Laurel Oldach","doi":"10.1021/cen-10137-scicon1","DOIUrl":"https://doi.org/10.1021/cen-10137-scicon1","url":null,"abstract":"Artificial intelligence and machine learning tools are already being used to power voice assistants and self-driving cars, determine what users see on the internet, and guide drug design and chemical syntheses. But there are concerns about their ability to push disinformation, compromise cybersecurity, and engineer harmful biological materials. Governments around the world hope to mitigate those risks without quashing progress in the problems that AI seems poised to solve. A recent executive order by US president Joe Biden announced measures to make AI systems safer, such as requiring their developers to search for ways that bad actors could exploit the tools. Shortly after the order’s announcement , government and corporation representatives gathered in the UK for a summit on the risks of AI; 28 countries signed a declaration that supports continuing development of the technology but calls for more research into its potential risks. Many parts of the chemical enterprise","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"54 12","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136283252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：